The popular diabetes drug Ozempic could be linked to a lower risk of cognitive problems, according to a new study conducted by researchers at the University of Oxford.

The study analyzed more than 100 million patient records in the United States, including over 20,000 who were taking semaglutide — commonly known as Ozempic or Wegovy.

Recommended Stories

Maria Bartiromo’s lawyer denies anchor’s firing and says she is still employed at Fox

Cybersecurity advocate Booz Allen says its system was hacked

MSNBC’s Nicolle Wallace leaves GOP ambassador husband for New York Times reporter